The forecasted average length of stay for pulmonary heart disease and diseases of pulmonary circulation in Canadian hospitals shows a steady decline from 2024 to 2028. Starting at 6.3 days in 2024, it decreases to 5.7 days by 2028. This indicates a notable reduction, with a year-on-year decline of approximately 3% between 2024 and 2025, slightly slowing to around 1.67% between 2027 and 2028. Over the five-year period, the compound annual growth rate (CAGR) shows a decline, highlighting ongoing improvements in treatment and management efficiency.

Future trends to watch for include:

Technological advancements in treatment that could further reduce hospital stays.
Policy changes influencing healthcare practices and patient care strategies.
Impact of an aging population on the demand for pulmonary disease management.